Weekly News Recap #Phispers
Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn
In this week’s Phispers, Novo Nordisk and Bristol Myers Squibb (BMS) struck multi-billion-dollar acquisitions to expand t...
Impressions : 1212
Sarepta lays off 500 employees post second death in Elevidys trial; FDA chief proposes lowering PDUFA fee
This week’s Phispers brings you updates on cell and gene therapies (CGTs). After the death of a second teenaged boy last ...
Impressions : 4478
Court dismisses Astra’s lawsuit over IRA price talks; Ozempic shows benefits to kidney, heart in diabetics with CKD
This week’s Phispers brings updates on the Inflation Regulation Act (IRA) in the US. A federal district court judge rejec...
Impressions : 1146
Sanofi-GSK join hands for Covid-19 vaccine; BMS awarded US$ 1.2 billion in major patent case win over Gilead
This week, Phispers brings you news about two key competitors in the field of vaccines — Sanofi and GSK — joining h...
Impressions : 2146
Novartis in crisis management mode; Elanco buys Bayer’s animal health business for US$ 7.6 billion
This week, Phispers updates you on the data manipulation at Novartis for its gene therapy Zolgensma.
The Swiss drugmaker is no...
Impressions : 4599
Novartis plans job cuts in Switzerland; Researcher pleads guilty of stealing GSK’s trade secrets
This week,
Phispers brings you details of the scam at GSK, wherein a former cancer
researcher in the US stole trade secrets f...
Impressions : 3572
2017 closes with record approvals of generics, novel drugs; 2018 begins with reprieves for Teva
PharmaCompass wishes its readers a very happy new year. We begin the year with an analysis of 2017, when we saw record approval...
Impressions : 4360
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.